ID   ANBM-6
AC   CVCL_M523
SY   ANBM6
DR   Wikidata; Q54749912
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8221668;
RX   PubMed=9022078;
RX   PubMed=10936422;
CC   Population: Caucasian.
CC   Characteristics: Produces Ig lambda.
CC   Characteristics: IL6 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5425 ! ANBL-6
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 13
//
RX   DOI=10.1007/0-306-46877-8_4;
RA   Jernberg-Wiklund H., Nilsson K.;
RT   "Multiple myeloma cell lines.";
RL   (In book chapter) Human cell culture. Vol. 3. Cancer cell lines part 3; Masters J.R.W., Palsson B.O. (eds.); pp.81-155; Kluwer Academic Publishers; New York; USA (2000).
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   PubMed=8221668;
RA   Jelinek D.F., Ahmann G.J., Greipp P.R., Jalal S.M., Westendorf J.J.,
RA   Katzmann J.A., Kyle R.A., Lust J.A.;
RT   "Coexistence of aneuploid subclones within a myeloma cell line that
RT   exhibits clonal immunoglobulin gene rearrangement: clinical
RT   implications.";
RL   Cancer Res. 53:5320-5327(1993).
//
RX   PubMed=9022078; DOI=10.1172/JCI119179; PMCID=PMC507818;
RA   Jelinek D.F., Aagaard-Tillery K.M., Arendt B.K., Arora T.,
RA   Tschumper R.C., Westendorf J.J.;
RT   "Differential human multiple myeloma cell line responsiveness to
RT   interferon-alpha. Analysis of transcription factor activation and
RT   interleukin 6 receptor expression.";
RL   J. Clin. Invest. 99:447-456(1997).
//
RX   PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2;
RA   Drexler H.G., Matsuo Y.;
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   multiple myeloma and plasma cell leukemia.";
RL   Leuk. Res. 24:681-703(2000).
//